Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research
Published in: Breast Cancer Research 1/2000

01-03-2000 | Meeting abstract

Expression of Akt kinases related to ErbB2 and results of adjuvant therapy of breast cancer

Authors: O Stal, L Akerberg, B Nordenskjold, B Olsson, LE Rutqvist, L Skoog

Published in: Breast Cancer Research | Special Issue 1/2000

Login to get access

Excerpt

It has been suggested in several studies of breast cancer that overexpression of the growth factor receptor erbB2 is associated with less benefit from certain adjuvant treatments. The mechanisms are not fully understood. The erbB2 receptor activates several signal pathways including the phosphatidyl-inositol-3-kinase (PI3-K)/Akt (also known as PKB) pathway, which is implicated in cell survival. This pathway has shown to be a target of the tumor suppressor PTEN. …
Metadata
Title
Expression of Akt kinases related to ErbB2 and results of adjuvant therapy of breast cancer
Authors
O Stal
L Akerberg
B Nordenskjold
B Olsson
LE Rutqvist
L Skoog
Publication date
01-03-2000
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue Special Issue 1/2000
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr106

Other articles of this Special Issue 1/2000

Breast Cancer Research 1/2000 Go to the issue

Oral presentation

Animal models of human tumor suppressor genes

Oral presentation

Two molecular cytogenetic views of breast cancer

Meeting abstract

Identification of two novel breast cancer associated genes by the differential display method

Meeting abstract

BRCA2 interacting proteins

Oral presentation

Molecular characteristics of inherited breast tumors

Oral presentation

Carcinoma-associated fibroblasts stimulate tumor progression of initiated human epithelium
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits